Φορτώνει......
Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague
Yersinia pestis, the causative agent of pneumonic plague, induces a highly lethal infection if left untreated. Currently, there is no FDA-approved vaccine against this pathogen; however, USAMRIID has developed a recombinant fusion protein, F1-V, that has been shown to induce protection against pneum...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Acta Biomater |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7012387/ https://ncbi.nlm.nih.gov/pubmed/31610342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.actbio.2019.10.016 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|